Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1998 1
2003 2
2004 1
2005 1
2006 1
2009 1
2012 1
2013 4
2015 1
2016 1
2017 3
2018 1
2019 5
2020 5
2021 3
2022 7
2023 3
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Bidard FC, Hardy-Bessard AC, Dalenc F, Bachelot T, Pierga JY, de la Motte Rouge T, Sabatier R, Dubot C, Frenel JS, Ferrero JM, Ladoire S, Levy C, Mouret-Reynier MA, Lortholary A, Grenier J, Chakiba C, Stefani L, Plaza JE, Clatot F, Teixeira L, D'Hondt V, Vegas H, Derbel O, Garnier-Tixidre C, Canon JL, Pistilli B, André F, Arnould L, Pradines A, Bièche I, Callens C, Lemonnier J, Berger F, Delaloge S; PADA-1 investigators. Bidard FC, et al. Lancet Oncol. 2022 Nov;23(11):1367-1377. doi: 10.1016/S1470-2045(22)00555-1. Epub 2022 Sep 29. Lancet Oncol. 2022. PMID: 36183733 Clinical Trial.
[Return to work after a cancer diagnosis].
Alleaume C, Bousquet PJ, Bouhnik AD, Peretti-Watel P, Bendiane MK. Alleaume C, et al. Rev Prat. 2019 Apr;69(4):449-453. Rev Prat. 2019. PMID: 31626505 Review. French.
The VIP-receptor system in neuroblastoma cells.
Muller JM, Philippe M, Chevrier L, Héraud C, Alleaume C, Chadéneau C. Muller JM, et al. Among authors: alleaume c. Regul Pept. 2006 Nov 15;137(1-2):34-41. doi: 10.1016/j.regpep.2006.06.014. Epub 2006 Sep 20. Regul Pept. 2006. PMID: 16989911 Review.
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
Berger F, Marce M, Delaloge S, Hardy-Bessard AC, Bachelot T, Bièche I, Pradines A, De La Motte Rouge T, Canon JL, André F, Arnould L, Clatot F, Lemonnier J, Marques S, Bidard FC; PADA-1 investigators. Berger F, et al. BMJ Open. 2022 Mar 3;12(3):e055821. doi: 10.1136/bmjopen-2021-055821. BMJ Open. 2022. PMID: 35241469 Free PMC article. Clinical Trial.
Jaagsiekte sheep retrovirus infection of lung slice cultures.
Cousens C, Alleaume C, Bijsmans E, Martineau HM, Finlayson J, Dagleish MP, Griffiths DJ. Cousens C, et al. Among authors: alleaume c. Retrovirology. 2015 Apr 9;12:31. doi: 10.1186/s12977-015-0157-5. Retrovirology. 2015. PMID: 25889156 Free PMC article.
44 results